209 related articles for article (PubMed ID: 12972030)
21. Activation of the canonical Wnt pathway leads to loss of hematopoietic stem cell repopulation and multilineage differentiation block.
Kirstetter P; Anderson K; Porse BT; Jacobsen SE; Nerlov C
Nat Immunol; 2006 Oct; 7(10):1048-56. PubMed ID: 16951689
[TBL] [Abstract][Full Text] [Related]
22. Role of PU.1 in hematopoiesis.
Fisher RC; Scott EW
Stem Cells; 1998; 16(1):25-37. PubMed ID: 9474745
[TBL] [Abstract][Full Text] [Related]
23. PU.1 phosphorylation correlates with hydroquinone-induced alterations in myeloid differentiation and cytokine-dependent clonogenic response in human CD34(+) hematopoietic progenitor cells.
Gross SA; Zheng JH; Le AT; Kerzic PJ; Irons RD
Cell Biol Toxicol; 2006 Jul; 22(4):229-41. PubMed ID: 16642264
[TBL] [Abstract][Full Text] [Related]
24. Transcription factors that regulate growth and differentiation of myeloid cells.
Nagamura-Inoue T; Tamura T; Ozato K
Int Rev Immunol; 2001 Feb; 20(1):83-105. PubMed ID: 11342299
[TBL] [Abstract][Full Text] [Related]
25. Negative cross-talk between hematopoietic regulators: GATA proteins repress PU.1.
Zhang P; Behre G; Pan J; Iwama A; Wara-Aswapati N; Radomska HS; Auron PE; Tenen DG; Sun Z
Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8705-10. PubMed ID: 10411939
[TBL] [Abstract][Full Text] [Related]
26. Cartography of hematopoietic stem cell commitment dependent upon a reporter for transcription factor activation.
Akashi K
Ann N Y Acad Sci; 2007 Jun; 1106():76-81. PubMed ID: 17360807
[TBL] [Abstract][Full Text] [Related]
27. Visualizing PU.1 activity during hematopoiesis.
Back J; Allman D; Chan S; Kastner P
Exp Hematol; 2005 Apr; 33(4):395-402. PubMed ID: 15781329
[TBL] [Abstract][Full Text] [Related]
28. PKCδ-induced PU.1 phosphorylation promotes hematopoietic stem cell differentiation to dendritic cells.
Hamdorf M; Berger A; Schüle S; Reinhardt J; Flory E
Stem Cells; 2011 Feb; 29(2):297-306. PubMed ID: 21732487
[TBL] [Abstract][Full Text] [Related]
29. Knockdown of Pu.1 by small interfering RNA in CD34+ embryoid body cells derived from mouse ES cells turns cell fate determination to pro-B cells.
Zou GM; Chen JJ; Yoder MC; Wu W; Rowley JD
Proc Natl Acad Sci U S A; 2005 Sep; 102(37):13236-41. PubMed ID: 16141339
[TBL] [Abstract][Full Text] [Related]
30. PU.1 functions in a cell-autonomous manner to control the differentiation of multipotential lymphoid-myeloid progenitors.
Scott EW; Fisher RC; Olson MC; Kehrli EW; Simon MC; Singh H
Immunity; 1997 Apr; 6(4):437-47. PubMed ID: 9133423
[TBL] [Abstract][Full Text] [Related]
31. PU.1: An ETS family transcription factor that regulates leukemogenesis besides normal hematopoiesis.
Gupta P; Gurudutta GU; Verma YK; Kishore V; Gulati S; Sharma RK; Chandra R; Saluja D
Stem Cells Dev; 2006 Aug; 15(4):609-17. PubMed ID: 16978063
[TBL] [Abstract][Full Text] [Related]
32. Dynamic regulation of PU.1 expression in multipotent hematopoietic progenitors.
Nutt SL; Metcalf D; D'Amico A; Polli M; Wu L
J Exp Med; 2005 Jan; 201(2):221-31. PubMed ID: 15657291
[TBL] [Abstract][Full Text] [Related]
33. The transcription factor PU.1 does not regulate lineage commitment but has lineage-specific effects.
McKercher SR; Henkel GW; Maki RA
J Leukoc Biol; 1999 Nov; 66(5):727-32. PubMed ID: 10577501
[TBL] [Abstract][Full Text] [Related]
34. Inflammatory signals directly instruct PU.1 in HSCs via TNF.
Etzrodt M; Ahmed N; Hoppe PS; Loeffler D; Skylaki S; Hilsenbeck O; Kokkaliaris KD; Kaltenbach HM; Stelling J; Nerlov C; Schroeder T
Blood; 2019 Feb; 133(8):816-819. PubMed ID: 30301719
[TBL] [Abstract][Full Text] [Related]
35. Direct interaction of PU.1 with oncogenic transcription factors reduces its serine phosphorylation and promoter binding.
Seshire A; Rößiger T; Frech M; Beez S; Hagemeyer H; Puccetti E
Leukemia; 2012 Jun; 26(6):1338-47. PubMed ID: 22105598
[TBL] [Abstract][Full Text] [Related]
36. Essential role of Jun family transcription factors in PU.1 knockdown-induced leukemic stem cells.
Steidl U; Rosenbauer F; Verhaak RG; Gu X; Ebralidze A; Otu HH; Klippel S; Steidl C; Bruns I; Costa DB; Wagner K; Aivado M; Kobbe G; Valk PJ; Passegué E; Libermann TA; Delwel R; Tenen DG
Nat Genet; 2006 Nov; 38(11):1269-77. PubMed ID: 17041602
[TBL] [Abstract][Full Text] [Related]
37. PU.1 is a lineage-specific regulator of tyrosine phosphatase CD45.
Anderson KL; Nelson SL; Perkin HB; Smith KA; Klemsz MJ; Torbett BE
J Biol Chem; 2001 Mar; 276(10):7637-42. PubMed ID: 11114304
[TBL] [Abstract][Full Text] [Related]
38. Role of transcription factors C/EBPalpha and PU.1 in normal hematopoiesis and leukemia.
Koschmieder S; Rosenbauer F; Steidl U; Owens BM; Tenen DG
Int J Hematol; 2005 Jun; 81(5):368-77. PubMed ID: 16158816
[TBL] [Abstract][Full Text] [Related]
39. PU.1/Spi-1 binds to the human TAL-1 silencer to mediate its activity.
Le Clech M; Chalhoub E; Dohet C; Roure V; Fichelson S; Moreau-Gachelin F; Mathieu D
J Mol Biol; 2006 Jan; 355(1):9-19. PubMed ID: 16298389
[TBL] [Abstract][Full Text] [Related]
40. Activation of CCAAT/enhancer-binding protein alpha or PU.1 in hematopoietic stem cells leads to their reduced self-renewal and proliferation.
Fukuchi Y; Ito M; Shibata F; Kitamura T; Nakajima H
Stem Cells; 2008 Dec; 26(12):3172-81. PubMed ID: 18787208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
